DK0680970T3 - Medrogestron. - Google Patents

Medrogestron.

Info

Publication number: DK0680970T3
Authority: DK; Denmark
Prior art keywords: alpha; beta; dione; ene; dimethylpregnan
Prior art date: 1994-05-05

Application number

DK95302934T

Other languages

English (en)

Inventor

Michael William Winkley

Robert Dempster Mitchell

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-05

Filing date

1995-04-28

Publication date

2000-12-27

1994-05-05 Priority claimed from US08/239,187 external-priority patent/US5428151A/en

1995-04-28 Application filed by American Home Prod filed Critical American Home Prod

2000-12-27 Application granted granted Critical

2000-12-27 Publication of DK0680970T3 publication Critical patent/DK0680970T3/da

Links

201000001320 Atherosclerosis Diseases 0.000 abstract 1
238000005698 Diels-Alder reaction Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000011109 contamination Methods 0.000 abstract 1
150000001990 dicarboxylic acid derivatives Chemical class 0.000 abstract 1
FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 abstract 1
HCFSGRMEEXUOSS-JXEXPEPMSA-N medrogestone Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(C)[C@@]1(C)CC2 HCFSGRMEEXUOSS-JXEXPEPMSA-N 0.000 abstract 1
229960000606 medrogestone Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
230000035755 proliferation Effects 0.000 abstract 1
210000002460 smooth muscle Anatomy 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000012453 solvate Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyridine Compounds (AREA)

DK95302934T 1994-05-05 1995-04-28 Medrogestron. DK0680970T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/239,187 US5428151A (en)	1994-05-05	1994-05-05	Medrogestrone production

Publications (1)

Publication Number	Publication Date
DK0680970T3 true DK0680970T3 (da)	2000-12-27

Family

ID=22901004

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK95302934T DK0680970T3 (da)	1994-05-05	1995-04-28	Medrogestron.
DK99200264T DK0955049T3 (da)	1994-05-05	1995-04-28	6beta-Hydroxy-6alfa, 17alfa-dimethylpregn-4-en-3,20-dion som inhibitor af glatmuskel-proliferation

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK99200264T DK0955049T3 (da)	1994-05-05	1995-04-28	6beta-Hydroxy-6alfa, 17alfa-dimethylpregn-4-en-3,20-dion som inhibitor af glatmuskel-proliferation

Country Status (11)

Country	Link
EP (1)	EP0955049B1 (da)
JP (1)	JP2007119500A (da)
KR (1)	KR100365601B1 (da)
AT (2)	ATE269087T1 (da)
DE (2)	DE69533178T2 (da)
DK (2)	DK0680970T3 (da)
ES (2)	ES2219995T3 (da)
HU (1)	HU226298B1 (da)
PT (2)	PT955049E (da)
SI (2)	SI0680970T1 (da)
TW (1)	TW390886B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP7129392B2 (ja) *	2018-10-26	2022-09-01	キヤノン株式会社	組成物、それを有する有機発光素子、表示装置、撮像装置、電子機器及び移動体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3170936A (en) *	1963-08-07	1965-02-23	American Home Prod	Process for the preparation of 6, 17alpha-dimethyl-4, 6-pregnadiene-3, 20-dione
JPS57106698A (en) *	1980-12-22	1982-07-02	Kyowa Hakko Kogyo Co Ltd	Easily absorbable map composition and preparation containing the same
JPS57106697A (en) *	1980-12-22	1982-07-02	Kyowa Hakko Kogyo Co Ltd	Easily absorbable map composition and preparation containing the same

1995
- 1995-01-10 TW TW084100148A patent/TW390886B/zh not_active IP Right Cessation
- 1995-04-28 DE DE69533178T patent/DE69533178T2/de not_active Expired - Lifetime
- 1995-04-28 ES ES99200264T patent/ES2219995T3/es not_active Expired - Lifetime
- 1995-04-28 PT PT99200264T patent/PT955049E/pt unknown
- 1995-04-28 DK DK95302934T patent/DK0680970T3/da active
- 1995-04-28 EP EP99200264A patent/EP0955049B1/en not_active Expired - Lifetime
- 1995-04-28 AT AT99200264T patent/ATE269087T1/de not_active IP Right Cessation
- 1995-04-28 DK DK99200264T patent/DK0955049T3/da active
- 1995-04-28 AT AT95302934T patent/ATE197798T1/de not_active IP Right Cessation
- 1995-04-28 SI SI9530427T patent/SI0680970T1/xx unknown
- 1995-04-28 DE DE69519488T patent/DE69519488T2/de not_active Expired - Lifetime
- 1995-04-28 SI SI9530705T patent/SI0955049T1/xx unknown
- 1995-04-28 PT PT95302934T patent/PT680970E/pt unknown
- 1995-04-28 ES ES95302934T patent/ES2151941T3/es not_active Expired - Lifetime
- 1995-05-03 KR KR1019950010792A patent/KR100365601B1/ko not_active Expired - Fee Related
- 1995-05-04 HU HU0600432A patent/HU226298B1/hu not_active IP Right Cessation
2007
- 2007-02-14 JP JP2007033723A patent/JP2007119500A/ja not_active Ceased

Also Published As

Publication number	Publication date
PT680970E (pt)	2001-04-30
EP0955049A3 (en)	2003-01-08
HK1009970A1 (en)	1999-06-11
EP0955049B1 (en)	2004-06-16
KR950032266A (ko)	1995-12-20
DE69533178D1 (de)	2004-07-22
EP0955049A2 (en)	1999-11-10
TW390886B (en)	2000-05-21
ES2219995T3 (es)	2004-12-01
ES2151941T3 (es)	2001-01-16
JP2007119500A (ja)	2007-05-17
ATE197798T1 (de)	2000-12-15
HU0600432D0 (en)	2006-07-28
SI0955049T1 (en)	2004-10-31
PT955049E (pt)	2004-09-30
SI0680970T1 (en)	2001-02-28
DK0955049T3 (da)	2004-10-11
KR100365601B1 (ko)	2003-12-24
DE69519488D1 (de)	2001-01-04
HU226298B1 (en)	2008-08-28
ATE269087T1 (de)	2004-07-15
DE69533178T2 (de)	2005-07-28
DE69519488T2 (de)	2001-06-07

Similar Documents

Publication	Publication Date	Title
EP0608838A3 (en)	1994-12-14	Method of producing an unsaturated carboxylic acid.
ATE172979T1 (de)	1998-11-15	Verfahren zur herstellung von d-maltose- monoestern mit einem hohen gehalt von 6-0'-ester und ihre verwendung in kosmetika, zahnpflegemitteln, pharmazeutik und lebensmitteln
EP0444640A3 (en)	1992-07-08	Process for biological production of organic acids
EP0460917A3 (en)	1993-07-07	Method of producing eicosapentaenoic acid or an ester derivative thereof
DE68913714D1 (de)	1994-04-14	Verfahren zur Herstellung von ungesättigter Carbonsäure oder ihrem Ester.
IT7925433A0 (it)	1979-08-31	Procedimento di produzione di acidi carbossilici e loro esteri.
DE69128123D1 (de)	1997-12-11	Verfahren zum Herstellen selbst-ausrichtender bipolarer Transistoren mit Heteroübergang
BE870855A (fr)	1979-03-28	Procede pour l'isolement d'acides organiques
ES2151941T3 (es)	2001-01-16	Medrogestona.
ATE140925T1 (de)	1996-08-15	Neues verfahren zur herstellung von 6alpha, 9alphadifluoro-sterioden und zwischenprodukte davon
FR2305422A1 (fr)	1976-10-22	Procede de carboxylation de substrats organiques avec de l'anhydride carbonique
DE69008070D1 (de)	1994-05-19	Verfahren zur Herstellung eines alpha-Ketocarbonsäureester.
HUT46742A (en)	1988-11-28	Process for production of esthers of carbonic acid
ATE11036T1 (de)	1985-01-15	Methacrylsaeureester als reaktivverduenner fuer oxidativ vernetzbare alkydharze und deren herstellung.
HU9202230D0 (en)	1992-10-28	Method for producing beta-lactames
DE69015931D1 (de)	1995-02-23	Verfahren zur Herstellung von 4-halogeno-2-alkoximino-3-oxo Fettsäuren.
ATE133650T1 (de)	1996-02-15	Verfahren und reinigung von essigsäureanhydrid und essigsäure
FR2686897B1 (fr)	1995-07-13	Procede en continu de fabrication d'acides organiques.
ATE128471T1 (de)	1995-10-15	Neues verfahren zur herstellung delta-9(11)- steroide.
DE69110374D1 (de)	1995-07-20	Verfahren zur erhöhung des alpha/beta-verhältnisses in einer aspartamkupplungsreaktion.
DE69005317D1 (de)	1994-02-03	Verfahren und Zwischenprodukte zur Herstellung von Isopropylestern von 3S-amino-2R-hydroxyalkansäuren.
JPS57193449A (en)	1982-11-27	Novel tin 2-nitrothiophenol complex compound, its preparation and preparation of threo substituted- propionic acid derivative with the same
KR920004350A (ko)	1992-03-27	5-알킬피리딘-2,3-디카르복실산에서 에스테르의 제조방법
CA2019718A1 (en)	1991-12-25	Echinacea extracts, a process for the preparation thereof and formulations containing them
BR9104254A (pt)	1992-06-02	Processo para producao de anidrido de acido carboxilico